STOCK TITAN

Option Care Health, Inc. - $OPCH STOCK NEWS

Welcome to our dedicated page for Option Care Health news (Ticker: $OPCH), a resource for investors and traders seeking the latest updates and insights on Option Care Health stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Option Care Health's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Option Care Health's position in the market.

Rhea-AI Summary
Option Care Health Inc. will release Q3 2023 results on October 25, 2023 before the market opens. A conference call will be held at 8:30 a.m. ET to review the results. Participants can pre-register for the call at the provided link. A replay will be available for on-demand listening.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.43%
Tags
-
Rhea-AI Summary
Option Care Health Inc. to participate in Morgan Stanley conference
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.75%
Tags
conferences
-
Rhea-AI Summary
Option Care Health, Inc. (OPCH) reports strong second quarter 2023 financial results, with net revenue up 9.0% to $1,069.1 million, gross profit up 15.6% to $250.8 million, and net income up 237.2% to $114.4 million. The company also updated its full year 2023 financial guidance, expecting net revenue of $4.2 billion to $4.3 billion, adjusted EBITDA of $415 million to $425 million, and cash flow from operations of at least $350 million.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.38%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.91%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.18%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.23%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.27%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.71%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4%
Tags
conferences
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
conferences
Option Care Health, Inc.

Nasdaq:OPCH

OPCH Rankings

OPCH Stock Data

5.22B
172.59M
0.55%
99.78%
2.64%
Pharmacies and Drug Stores
Retail Trade
Link
United States of America
BANNOCKBURN

About OPCH

as of august 7, 2019, option care and bioscrip have merged to become one national team, solely dedicated to infusion care. option care health, inc. is the largest independent home and alternate site infusion services provider in the united states. with over 6,000 teammates including 2,900 clinicians, we work compassionately to elevate standards of care for patients with acute and chronic conditions in all 50 states. through our clinical leadership, expertise and national scale, option care health is reimagining the infusion care experience for patients, customers and employees.